Hanson & Doremus Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Hanson & Doremus Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-515	Closed	-$28K	–	483
2016 Q1	$28K	Hold	515	–	–	0.01%	293
2015 Q4	$58K	Hold	515	–	–	0.03%	251
2015 Q3	$61K	Hold	515	–	–	0.03%	241
2015 Q2	$40K	Hold	515	–	–	0.02%	277
2015 Q1	$30K	Hold	515	–	–	0.01%	302
2014 Q4	$17K	Hold	515	–	–	0.01%	347
2014 Q3	$13K	Hold	515	–	–	0.01%	350
2014 Q2	$9K	Buy	+515	New	+$8.29K	﹤0.01%	370

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Hanson & Doremus Investment Management's ANAC Position: Q2 2016 in Review

Hanson & Doremus Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 515 shares — an estimated $28K sold.

Hanson & Doremus Investment Management first reported a position in ANAC in Q2 2014 and held it in 8 quarters. The position peaked at $61K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Hanson & Doremus Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Hanson & Doremus Investment Management sold 515 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $28K.
Hanson & Doremus Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 8 quarters.
Hanson & Doremus Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $61K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2016, filed 29 Jul 2016.